<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Iranian Heart Association</PublisherName>
				<JournalTitle>Iranian Heart Journal</JournalTitle>
				<Issn></Issn>
				<Volume>6</Volume>
				<Issue>1.2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2005</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>EVALUATION OF ASSOCIATION BETWEEN MVP SYNDROME AND KERATOCONUS</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>68</FirstPage>
			<LastPage>71</LastPage>
			<ELocationID EIdType="pii">84131</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Z.</FirstName>
					<LastName>AKBARZADEH</LastName>
<Affiliation>Dept of Echocardiography, Shaheed Rajaee Cardiovascular Medical Center, Mellat Park, Vali Asr Avenue, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>A.</FirstName>
					<LastName>MOHEBI</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>M.</FirstName>
					<LastName>FORGHANIFARD</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>M.</FirstName>
					<LastName>MALEKI</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>F.</FirstName>
					<LastName>NOUHI</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Z.</FirstName>
					<LastName>OJAGHI</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>M.A.</FirstName>
					<LastName>JAVADI</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>N.</FirstName>
					<LastName>RAFATI</LastName>
<Affiliation></Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>03</Month>
					<Day>07</Day>
				</PubDate>
			</History>
		<Abstract>Background- According to previous studies, it appears that there is a 4.2% chance of keratoconus in patients with the MVP syndrome. Also, keratoconus is seen as a part of systemic disorders like atopia, mitral valve prolapse, Down&#039;s syndrome, osteogenesis imperfecta and hypermobility of joints. More studies have dedicated concurrent evidence between keratoconus and the MVP syndrome. In a recent study performed in Tehran, an association between the MVP syndrome and keratoconus was confirmed. We also wanted to evaluate an inverse relationship in MVP patients.&lt;br /&gt;Methods- 392 patients with the MVP syndrome based on findings in physical exam and echocardiography evaluation (Ving Med 750-800 with 2.5 MHZ phased array transducer) were referred to an optometrist to have cornea examination by videokeratography (topography Humphrey system) and assessment of keratoconus findings.&lt;br /&gt;Results- There is no relationship between the MVP syndrome and keratoconus. &lt;br /&gt;Conclusion-Our findings do not support the hypothesis that MVP is a part of systemic diseases that include keratoconus.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">mitral valve prolapse</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">KERATOCONUS CONUS</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.iha.org.ir/article_84131_7db6ca85a15f53f8c59fa4c56905020e.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
